Summary of Qualifications: Over nine years as CRA and ten years as CCRC performing site management of phases I-IV clinical trials with large and mid-sized pharmaceutical sponsors and international CROs: INC Research/inVentiv Health Clinical, Pfizer, United Therapeutics Inc., Clinipace Worldwide (Formerly Paragon Biomedical), GeNO LLC, PAREXEL, Merck, Astra Zeneca/MedImmune, GlaxoSmithKline Actelion, Gilead Sciences, INO Therapeutics. Therapeutic clinical trial experience includes: Therapeutic Area, Sub Indication and Drug Class Phase Job Title Pain/Osteoarthritis/NGFI III CRA Pain/Chronic Lower Back/NGFI III CRA Pulmonary/Pulmonary Arterial Hypertension (PAH)/Prostaglandin III CRA, CRC Vaccine/Influenza III CRA Allergy/Asthma/anti IGE-antibody III CRA Oncology/Solid tumor/MAB I/Ib CRA Oncology/Metastatic Kidney /Protein Kinase Inhibitor Ib/II CRA PAH/Idiopathic Pulmonary Fibrosis (IPF)/inhaled vasodilator II CRA Pulmonary/PAH/Inhaled Vasodilator delivery system II CRA Migraine/Pediatric/Serotonin 1b-1d receptor agonist III CRA Neurology/Epilepsy/anti-Epileptic III CRA Vaccine/Hepatitis B/TLR9 agonist III CRA Infection/HIV/antiretroviral III CRA Infection/Sepsis/Anti-TNF I CRA Pulmonary/PAH/PDE-5 inhibitor III CRC

Highlights:

• Management
• Pulmonary
• Clinical Research
• Documentation
• Research
• Protocol
• Allergy
• Applications
• Assessments
• Biomedical Industry